The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model. (Q46104609)
Jump to navigation
Jump to search
scientific article published on 27 February 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model. |
scientific article published on 27 February 2009 |
Statements
The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model (English)
Eric I Rossman
Kun Liu
Gwen A Morgan
Robert E Swillo
Julie A Krueger
Stephen J Gardell
John Butera
Matthew Gruver
Joel Kantrowitz
Hal S Feldman
Jørgen S Petersen
27 February 2009